Highly efficient immunoliposomes prepared with a method which is compatible with various lipid compositions
- PMID: 2610692
- DOI: 10.1016/0006-291x(89)92740-x
Highly efficient immunoliposomes prepared with a method which is compatible with various lipid compositions
Abstract
Monoclonal antibody was conjugated to N-glutaryl-phosphatidylethanolamine in the presence of octylglucoside by using N-hydroxysulfosuccinimide as a carboxyl-activation reagent. The conjugated antibody was then incorporated into liposomes by a simple dialysis method. The method is mild and is compatible with various lipid compositions of the liposomes. We have prepared immunoliposomes containing a lung endothelium-specific monoclonal antibody and showed excellent target binding (approximately 75% injected dose) of the immunoliposomes in mouse. Immunoliposomes can be prepared to contain other acidic lipids such as phosphatidylserine and various amounts of cholesterol. The presence of 20% or more cholesterol in liposomes resulted in high level of target binding. We have used in these experiments a new radioactive lipid-phase marker, 111In-DTPA-SA, which was very stable in vivo. The halflife of clearance in mouse exceeded 3 weeks.
Similar articles
-
Lipid composition is important for highly efficient target binding and retention of immunoliposomes.Proc Natl Acad Sci U S A. 1990 Aug;87(15):5744-8. doi: 10.1073/pnas.87.15.5744. Proc Natl Acad Sci U S A. 1990. PMID: 2377612 Free PMC article.
-
Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model.Cancer Chemother Pharmacol. 1995;35(6):447-56. doi: 10.1007/BF00686828. Cancer Chemother Pharmacol. 1995. PMID: 7882453
-
Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies.Biochim Biophys Acta. 1995 Mar 8;1234(1):74-80. doi: 10.1016/0005-2736(94)00263-o. Biochim Biophys Acta. 1995. PMID: 7880861
-
PEG-immunoliposome.Biosci Rep. 2002 Apr;22(2):251-66. doi: 10.1023/a:1020138622686. Biosci Rep. 2002. PMID: 12428903 Review.
-
In vivo targeting by liposomes.Biol Pharm Bull. 2000 Jul;23(7):791-9. doi: 10.1248/bpb.23.791. Biol Pharm Bull. 2000. PMID: 10919354 Review.
Cited by
-
Formulation, characterization and tissue distribution of a novel pH-sensitive long-circulating liposome-based theranostic suitable for molecular imaging and drug delivery.Int J Nanomedicine. 2016 Nov 1;11:5697-5708. doi: 10.2147/IJN.S111274. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27843312 Free PMC article.
-
Lipid composition is important for highly efficient target binding and retention of immunoliposomes.Proc Natl Acad Sci U S A. 1990 Aug;87(15):5744-8. doi: 10.1073/pnas.87.15.5744. Proc Natl Acad Sci U S A. 1990. PMID: 2377612 Free PMC article.
-
Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model.Cancer Chemother Pharmacol. 1995;35(6):447-56. doi: 10.1007/BF00686828. Cancer Chemother Pharmacol. 1995. PMID: 7882453
-
Immunotargeting of liposomes containing lipophilic antitumor prodrugs.Pharm Res. 1993 Apr;10(4):507-14. doi: 10.1023/a:1018933632318. Pharm Res. 1993. PMID: 8483832
-
Radiolabeled Liposomes for Nuclear Imaging Probes.Molecules. 2023 Apr 28;28(9):3798. doi: 10.3390/molecules28093798. Molecules. 2023. PMID: 37175207 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources